Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

chartwell rx, llc - isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - isoniazid tablets are recommended for all forms of tuberculosis in which organisms are susceptible. however, active tuberculosis must be treated with multiple concomitant anti-tuberculosis medications to prevent the emergence of drug resistance. single-drug treatment of active tuberculosis with isoniazid or any other medication, is inadequate therapy. isoniazid tablets are recommended as preventive therapy for the following groups, regardless of age. (note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis): - persons with human immunodeficiency virus (hiv) infection (greater than or equal to 5 mm) and persons with risk factors for hiv infection whose hiv infection status is unknown but who are suspected of having hiv infection. preventive therapy may be considered for hiv infected persons who are tuberculin-negative but belong to groups in which the prevalence of tuberculosis infection is high. candidates for preventive therapy who have

Singapore - engleză - HSA (Health Sciences Authority)

medicell pharmaceutical (s) pte. ltd. - isoniazid - tablet - 300 mg - isoniazid 300 mg

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

ax pharmaceutical corp - isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) -

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

ax pharmaceutical corp - isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - isoniazid 4950 g in 5000 g

Armenia - engleză - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

macleods pharmaceuticals ltd. - isoniazid - tablets - 300mg

Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - isoniazid - oral tablet - 100mg

Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - isoniazid - oral tablet - 100mg

Tanzania - engleză - Tanzania Medicinces & Medical Devices Authority

macleods pharmaceuticals limited, india - isoniazid - tablets - 100 mg

Tanzania - engleză - Tanzania Medicinces & Medical Devices Authority

macleods pharmaceuticals limited, india - isoniazid - dispersible tablets - 100

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - rifampin (unii: vjt6j7r4tr) (rifampin - unii:vjt6j7r4tr), isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l), pyrazinamide (unii: 2kni5n06ti) (pyrazinamide - unii:2kni5n06ti) - rifampin 120 mg - rifater is indicated in the initial phase of the short-course treatment of pulmonary tuberculosis. during this phase, which should last 2 months, rifater should be administered on a daily, continuous basis (see dosage and administration). following the initial phase and treatment with rifater, treatment should be continued with rifampin and isoniazid (e.g., rifamate) for at least 4 months. treatment should be continued for a longer period of time if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is hiv positive. in the treatment of tuberculosis, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. bacteriologic smears or cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to r